Clinical Trial Update: Temozolomide 12 Cycles Versus 6 Cycles of Standard First-line Treatment in Patients With Glioblastoma. [Phase 2]

View source ↗

Summary

Phase 2 trial comparing 12 cycles versus 6 cycles of standard first-line temozolomide treatment in glioblastoma; results completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma

Drugs mentioned

• Temozolomide (Temozolomide)

Snippet

Sponsor: Grupo Español de Investigación en Neurooncología | Conditions: Glioblastoma | Phase 2 | Status: COMPLETED | Results posted: 2021-01-12